Description
California Immunology Research Bond Proposition concerns Proposition 38, a statewide ballot measure on November 3, 2026. It would authorize California to borrow $8.4 billion to fund immune-system–focused medical research addressing cancer, heart disease, and Alzheimer’s. The market settles Yes if the measure is approved by a majority in the 2026 general election; otherwise, it settles No. If voting does not occur or results are not definitively known by March 31, 2027, the market resolves to No, based on credible reporting or official California state sources.
Event stats
Market highlights
Related events
Markets
Outcome | Odds | Spread | 24h Change | 24h Volume | Total Volume | Liquidity | |
|---|---|---|---|---|---|---|---|
| California Immunology Research Bond Proposition | — | — | — | — | — | — |
Rules
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).